As obesity drugs soar, Mass. biotechs seek a slice of the market
Several biotechs in Mass. are seeking to elbow their way into the lucrative market, which is currently dominated by Denmark’s Novo Nordisk, which makes Wegovy and Ozempic, and Eli Lilly, which produces Mounjaro.
Source: bostonglobe.com